Financial Trends -- 5.5/10
DocuSign has stabilized after a sharp post-pandemic deceleration, with revenue growth bottoming near
8% and showing early signs of re-acceleration. The IAM (Intelligent Agreement Management) platform
now represents
10.8% of ARR after 18 months, up from 2.3%
at end of FY2025. Non-GAAP operating margin expanded from 20% to
30.1% over four years, and FCF crossed $1B
for the first time at
$1,059M. However, revenue growth remains
mid-single digits, DNR at 102% is sub-par for SaaS, and EPS growth is decelerating as margin
expansion nears its ceiling. The company is in a "show me" phase.
Weight: 25%
FY2026 Revenue Growth
+8.2%
+40 bps YoY | Slight re-acceleration from 7.8%
FY2026 Non-GAAP Op Margin
30.1%
+30 bps YoY | +1,010 bps over 4 years
FY2026 Free Cash Flow
$1,059M
32.9% FCF margin | +15% YoY | First $1B+ year
FY2026 Billings Growth
+9.5%
+270 bps YoY | Notable re-acceleration from 6.8%
Annual Financial Summary (USD M, FYE January 31)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Total Revenue | 2,107M | 2,516M | 2,762M | 2,977M | 3,220M |
| Rev YoY | — | +19.4% | +9.8% | +7.8% | +8.2% |
| Subscription Revenue | 2,037M | 2,442M | 2,687M | 2,901M | 3,151M |
| Sub Rev YoY | — | +19.9% | +10.0% | +8.0% | +8.6% |
| Billings | 2,358M | 2,660M | 2,911M | 3,110M | 3,406M |
| Billings YoY | — | +12.8% | +9.4% | +6.8% | +9.5% |
| ARR | — | — | 2,805M | 3,030M | 3,272M |
| ARR YoY | — | — | — | +8.0% | +8.0% |
| IAM % of ARR | — | — | — | 2.3% | 10.8% |
| Non-GAAP Gross Margin | 82.0% | 82.0% | 83.0% | 82.2% | 82.0% |
| GAAP Op Margin | -3.0% | -3.0% | 1.0% | 6.7% | 9.3% |
| Non-GAAP Op Margin | 20.0% | 21.0% | 26.0% | 29.8% | 30.1% |
| Non-GAAP Diluted EPS | $1.98 | $2.03 | $2.98 | $3.55 | $3.84 |
| GAAP Diluted EPS | ($0.36) | ($0.49) | $0.36 | $5.08* | $1.48 |
| Free Cash Flow | 445M | 429M | 887M | 920M | 1,059M |
| FCF Margin | 21.1% | 17.1% | 32.1% | 30.9% | 32.9% |
| Shares Outstanding | 199M | 202M | 205M | 202M | 194M |
Note: DocuSign reports under US GAAP in USD. Fiscal year ends January 31 (FY = CY + 1).
All figures in millions of USD except per-share data and percentages.
*FY2025 GAAP EPS includes a one-time tax valuation allowance release.
Revenue growth stabilized at ~8% after a severe post-pandemic deceleration (19.4% to 7.8%).
FY2026 revenue of
$3,220M grew 8.2%, a modest +40 bps improvement
over FY2025. Billings re-accelerated more meaningfully to +9.5% at
$3,406M. Non-GAAP operating margin reached
30.1%, up +1,010 bps over 4 years. FCF crossed $1B for
the first time at
$1,059M (32.9% margin). Shares reduced 5.4% from
205M (FY2024) to
194M (FY2026) via aggressive buybacks ($869M in FY2026).
Quarterly Revenue, Billings, and Margin Trend
| Metric | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 660M | 661M | 688M | 700M | 712M | 710M | 736M | 755M | 776M | 764M | 801M | 818M | 837M |
| Rev YoY | — | — | — | — | +8.0% | +7.3% | +7.0% | +7.8% | +9.0% | +7.6% | +8.8% | +8.4% | +7.8% |
| Billings | 739M | 675M | 711M | 692M | 833M | 710M | 725M | 752M | 923M | 740M | 818M | 829M | 1,019M |
| Billings YoY | — | — | — | — | +12.7% | +5.2% | +1.9% | +8.7% | +10.8% | +4.2% | +12.9% | +10.2% | +10.4% |
| Non-GAAP Op Margin | 24% | 27% | 25% | 27% | 25% | 28.5% | 32.2% | 29.6% | 28.8% | 29.5% | 29.8% | 31.4% | 29.5% |
Billings volatility remains high due to early renewals; company transitioning to ARR reporting.
Quarterly billings range from $675M (Q1 FY24) to $1,019M (Q4 FY26), making quarter-over-quarter trends
unreliable. Q4 FY26 billings of $1,019M grew +10.4% YoY, while Q1 FY26 billings of $740M grew only
+4.2% YoY. Non-GAAP operating margin was consistently in the 28-32% band across all quarters, with
Q2 FY25 peaking at 32.2% and Q4 FY24 at 25%.
Dollar Net Retention (DNR)
| Metric | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q2 FY26 | Q3 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|---|---|
| DNR | ~98% | ~99% | ~100% | 100% | 101% | ~102% | 102% | 102% |
DNR bottomed at ~98% in Q4 FY2024 and recovered to 102% -- directionally positive but still sub-par for SaaS.
Premium SaaS names typically carry 110%+ DNR. Management guides for "another year of modest improvement"
in FY2027. IAM renewal cohorts show retention "several percentage points higher than the company average,"
which should gradually lift the blended number as IAM mix increases.
Acceleration / Deceleration Analysis
| Signal | Detail | Direction |
|---|---|---|
| Revenue Growth | 19.4% (FY23) to 9.8% (FY24) to 7.8% (FY25) to 8.2% (FY26); +40 bps | Stabilizing |
| Billings Growth | 12.8% (FY23) to 6.8% (FY25) to 9.5% (FY26); +270 bps re-acceleration | Re-accelerating |
| Non-GAAP EPS Growth | +46.8% (FY24) to +19.1% (FY25) to +8.2% (FY26); margin ceiling effect | Decelerating |
| Non-GAAP Op Margin | 20% to 30.1% over 4 years; FY27 guided at 30.0-30.5% (flat) | Plateauing |
| FCF Growth | -3.6% (FY23) to +106.7% (FY24) to +3.7% (FY25) to +15.0% (FY26) | Re-accelerating |
| Non-GAAP Gross Margin | 83% (FY24) to 82% (FY26); flat-to-declining due to cloud migration costs | Declining |
| Dollar Net Retention | ~98% (Q4 FY24) to 102% (Q4 FY26); steady recovery over 8 quarters | Improving |
| Share Count | 205M (FY24) to 194M (FY26); -5.4% reduction via $869M buyback | Shrinking |
Penalty / Modifier Assessment
| Factor | Impact | Detail |
|---|---|---|
| Revenue stabilization / slight re-acceleration | +0.5 | +40 bps YoY in FY2026, breaking multi-year deceleration trend. |
| Billings re-acceleration | +0.5 | +270 bps to 9.5% in FY2026 from 6.8% in FY2025. |
| DNR recovery | +0.5 | 98% to 102% over 8 quarters; directionally correct. |
| FCF crossed $1B milestone | +0.5 | 33% margin, +15% growth re-acceleration. |
| Margin expansion impressive | +0.5 | Non-GAAP op margin 20% to 30%; GAAP margin -3% to +9.3%. |
| Aggressive buyback | +0.5 | -5.4% share reduction; $2.6B new authorization. |
| IAM credible growth vector | +0.5 | $350M+ ARR after 18 months, 25k+ customers, strong retention. |
| Mid-single-digit revenue growth profile | -1.5 | 7-8% growth is mature/slow. FY27 guided at ~8%, no acceleration. |
| Severe post-pandemic deceleration | -1.0 | 19.4% to 7.8% was a -1,160 bps collapse; re-acceleration is modest. |
| DNR sub-par for SaaS | -0.5 | 102% vs 110%+ for premium SaaS; limits organic expansion. |
| EPS growth decelerating | -0.5 | 47% to 19% to 8% as margin ceiling approached. |
| Gross margin flat/declining | -0.5 | 83% to 82%; cloud migration costs; no gross margin leverage. |
| Op margin plateau at ~30% | -0.5 | FY27 guided 30.0-30.5%. Limited further cost-cutting upside. |
| Growth re-acceleration aspirational | -0.5 | Double-digit growth talked about for years; not yet achieved. |
Final Score: 5.5 / 10. DocuSign has successfully stabilized after
a sharp post-pandemic deceleration, with impressive profitability improvements and strong FCF generation.
The IAM platform is a credible growth catalyst, but it has not yet translated into meaningful top-line
acceleration -- revenue growth remains at 8% with no inflection in the FY2027 guide. DNR improvement is
directionally positive but still sub-par for SaaS. The company is in a "show me" phase where the market
is waiting for IAM to translate into tangible growth acceleration. A score above 6 would require
demonstrated revenue inflection toward double-digit growth and DNR approaching 105%+.
Transcript Context (Q3 FY2025 - Q4 FY2026 Earnings Calls)
IAM Pivot and Monetization: IAM now represents 10.8% of ARR ($350M+) after just
18 months, up from 2.3% at end of FY2025. Guided to ~18% of ARR (~$640M) by end of FY2027.
Fastest-growing new product in DocuSign history with 25,000+ paying customers. First renewal cohorts
performing "several percentage points" better than company average on gross retention. Launching
consumption-based pricing in Q1 FY2027 and new departmental SKUs (IAM for HR, procurement).
AI processing costs optimized by 50x compared to running direct LLM prompts.
200M+ consented private agreements ingested into Navigator (up from 150M in Dec 2025).
Growth Trajectory: Allan Thygesen (Q4 FY2026): "We are positioned to begin
accelerating the business." FY2027 ARR guidance: 8.25%-8.75% growth (slight acceleration from 8%
in FY2026). Revenue guidance: ~8% for FY2027 -- essentially flat with FY2026. Long-term aspiration
remains "sustainable double-digit top-line growth" but management has not put a timeline on it.
Macro / Risk Factors: Stock is down ~49% from 52-week highs, trading near 52-week
lows at $48.37. Forward P/E of ~10.9x is very cheap for SaaS but reflects market skepticism about
growth re-acceleration. Early renewals create significant billings volatility quarter-to-quarter
(company transitioning to ARR reporting to reduce noise).
Daloopa and DocuSign, Inc. earnings call transcripts (Q3 FY2025 - Q4 FY2026)